Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
Relay Therapeutics (RLAY) Stock Price & Analysis
274 Followers
RLAY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.95 - $19.23
Previous Close$8.3
Volume679.76K
Average Volume (3M)1.10M
Market Cap
$1.09B
Enterprise Value$992.06M
Total Cash (Recent Filing)$151.33M
Total Debt (Recent Filing)$54.60M
Price to Earnings (P/E)-3.0
Beta1.90
Next Earnings
May 02, 2024EPS Estimate
-$0.74Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.79
Shares Outstanding131,179,034
10 Day Avg. Volume1,535,523
30 Day Avg. Volume1,104,649
Standard Deviation0.19
R-Squared0.19
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.43
Price to Sales (P/S)4303.50
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue38.45
Enterprise Value/Gross Profit718.36
Enterprise Value/Ebitda-2.77
Forecast
1Y Price Target
$20.37Price Target Upside145.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Relay Therapeutics News
Ownership Overview
Currently, No data available
---
RLAY FAQ
What was Relay Therapeutics’s price range in the past 12 months?
Relay Therapeutics lowest stock price was $5.95 and its highest was $19.23 in the past 12 months.
What is Relay Therapeutics’s market cap?
Currently, no data Available
When is Relay Therapeutics’s upcoming earnings report date?
Relay Therapeutics’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were Relay Therapeutics’s earnings last quarter?
Relay Therapeutics released its earnings results on Feb 22, 2024. The company reported -$0.67 earnings per share for the quarter, beating the consensus estimate of -$0.718 by $0.048.
Is Relay Therapeutics overvalued?
According to Wall Street analysts Relay Therapeutics’s price is currently Undervalued.
Does Relay Therapeutics pay dividends?
Relay Therapeutics does not currently pay dividends.
What is Relay Therapeutics’s EPS estimate?
Relay Therapeutics’s EPS estimate is -$0.74.
How many shares outstanding does Relay Therapeutics have?
Relay Therapeutics has 131,179,030 shares outstanding.
What happened to Relay Therapeutics’s price movement after its last earnings report?
Relay Therapeutics reported an EPS of -$0.67 in its last earnings report, beating expectations of -$0.718. Following the earnings report the stock price went down -5.393%.
Which hedge fund is a major shareholder of Relay Therapeutics?
Among the largest hedge funds holding Relay Therapeutics’s share is Baker Bros Advisors LP. It holds Relay Therapeutics’s shares valued at 13M.
---
Relay Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.37 (145.42% Upside)
$20.37 (145.42% Upside)
Blogger Sentiment
Bullish
RLAY Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $98.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.2%
Last 30 Days ▼ 2.0%
Last 30 Days ▼ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.66%
12-Months-Change
Fundamentals
Return on Equity
-40.18%
Trailing 12-Months
Asset Growth
-23.26%
Trailing 12-Months
Company Description
Relay Therapeutics
Relay Therapeutics Inc is a precision medicines company focused on enhancing small molecule therapeutic discovery in targeted oncology. Its pipeline products include RLY-1971 and RLY-4008 and among others.
---
RLAY Stock 12 Months Forecast
Average Price Target
$20.37
▲(145.42% Upside)
Technical Analysis
Best Analysts Covering RLAY
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
-25.34%
reiterated a buy rating 2 months ago
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -25.34% per trade.
---